🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05450835
Recruiting Not applicable

OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method

NCT05450835 · tracked via the Priya Life Science China tracker
Sponsor
Nanfang Hospital, Southern Medical University
Phase
Not applicable
Started
2022-09-01
Last updated
2025-05-31

Condition(s) studied

Gastric Cancer

Investigational drug(s) / intervention(s)

OGT groupOverlap group

OGT group: In OGT group,the nasogastric tube was pulled out 3 cm from the oesophagal lumen to connect with the OGT. Meanwhile, the OGT was sleeved on anvil fork extracorporeally and the linear stapler was put into abdomen through trocar on the right side and then cartridge fork was inserted through jejunum opening towards the oral side of the lumen. Next, the anvil fork sleeved with OGT insert into the oesophageal mucosa canal by movement of the connection of fork -OGT -gastric tube.

Overlap group: In overlap group, the oesophagojejunostomy was performed as reported by Inaba et al.

Study summary

Abstract Background Our previous studies have shown OGT method significantly simplified overlap esophagojejunostomy with good short-term outcomes, and provided new perspectives for optimizing esophagojejunostomy. However, the safety and efficiency of OGT method still need evidence of randomized controlled trial.

Methods: This trial is a prospective, multicenter, randomized, controlled, open, and superiority trial. Three hundred and forty-four patients who met the inclusion criteria and did not accord with the exclusion criteria will be randomly divided into OGT group(n=172) and traditional group(n=172). The primary purpose of this study is to evaluate time of oesophagojejunostomy of OGT method compared with traditional method for Siewert III/II esophagogastric junction cancer and gastric cancer. The second purpose is to evaluate the success rate of inserting anvil fork into esophageal lumen at first attempt, attempts of inserting anvil fork into esophagus, early postoperative complications,recovery course and compare the postoperative hospital stay of the patients enrolled in this study.

Discussion: This trial is the first prospective randomized two-arm controlled study to determine the safety and efficiency of OGT method compared with traditional overlap method. Through this trial, we hope to show that experienced surgeons can safely perform OGT-assisted overlap esophagojejunostomy for Siewert III/II esophagogastric junction cancer and gastric cancer.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Aged 18-75 years; * Primary lesion is pathologically diagnosed as gastric adenocarcinoma; * Expected to live more than 1 year; * Tumor located located in gastroesophageal junction (GEJ) involve esophagus no more than 2cm, or in the upper, upper to middle, or entire stomach, and intend to perform laparoscopic total gastrectomy with D2 lymphadenectomy * No history of upper abdominal surgery (except for laparoscopic cholecystectomy); * Preoperative performance status (ECOG, Eastern Cooperative Oncology Group) of 0 or 1; * Preoperative ASA (American Society of Anesthesiologists) scoring: I-III; * Without preoperative radiotherapy; * Did not found metastasis preoperatively and intraoperatively; * Sufficient organ functions; * Written informed consent. Exclusion Criteria: * Women during pregnancy or breast-feeding; * Body temperature ≥ 38 °C before surgery or infectious disease with a systemic therapy indicated; * Severe mental disease; * Confirmed stage IV (AJCC 8th) during surgery * Severe respiratory disease; * Severe hepatic and renal dysfunction; * Unstable angina pectoris or history of myocardial infarction within 6 months; * History of cerebral infarction or cerebral hemorrhage within 6 months; * Gastric cancer complications (bleeding, perforation, obstruction) that requiring emergency surgery; * Performing hyperthermic intraperitoneal chemotherapy (HIPEC) after surgery.

Primary outcome measure(s)

Trial sites (12)

FacilityCityRegionStatus
Fujian Medical University 2nd Affiliated Hoapital Quanzhou Fujian Recruiting
Nanfang Hospital Guangzhou Guangdong Completed
Guangdong Provincial People's Hospital Guangzhou Guangdong Recruiting
Sixth affiliated hospital of Sun Yat-sen University Guangzhou Guangdong Completed
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine Guangzhou Guangdong Recruiting
The First Affiliated Hospital of Shantou University Medical College Shantou Guangdong Recruiting
Ganzhou City People Hospital Ganzhou Guangxi Recruiting
The Third Xiangya Hospital of Central South University Changsha Hunan Completed
The First Affiliated Hospital of Nanhua University Hengyang Hunan Completed
The First Hospital Of Jilin University Changchun Jilin Completed
The First Hospital of China Medical University Shenyang Liaoning Completed
The People's Hospital of Changzhi Changzhi Shanxi Completed

More Nanfang Hospital, Southern Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05450835 on ClinicalTrials.gov ↗ ← All trials in China